Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 66

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 66
---
 securities are prohibited. Pledging DiaMedica’s securities as collateral to secure loans is also prohibited. This prohibition means, among other things, that directors, officers and employees cannot hold DiaMedica’s securities in a “margin account.” |

The information contained in this“Anti-Hedging and Pledging Policy”section shall not be deemed to be“soliciting material”or to be“filed”with the SEC, or subject to Regulation 14A or 14C or to the liabilities of Section 18 of the Exchange Act, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.

<div align='center'>55

RELATED PERSON RELATIONSHIPS AND TRANSACTIONS</div>

Introduction

Below under “—Description of Related Party Transactions” is a description of transactions that have occurred during the past two fiscal years, or any currently proposed transactions, to which we were or are a participant and in which:

| ● | the amounts involved exceeded or will exceed the lesser of: $120,000 or one percent of the average of our total assets at year end for the last two completed fiscal years; and |

| ● | a related person (including any director, director nominee, executive officer, holder of more than five percent of our common shares or any member of their immediate family) had or will have a direct or indirect material interest. |

Description of Related Party Transactions

Insider Stock Purchases

On June 25, 2024, we issued and sold an aggregate 4,720,000 common shares pursuant to a securities purchase agreement at a purchase price of $2.50 per share in a private placement. As a result of the offering, we received gross proceeds of $11.8 million, which resulted in net proceeds to us of approximately $11.7 million, after deducting the offering expenses. The following beneficial owners of more than five percent of our common shares participated in the private placement:

| Beneficial Owner |     | Total Purchase 
 Price          |           |     | Number of Common 
 Shares Purchased |           |
|:-----------------|:----|:---------------|----------:|:----|:-----------------|----------:|
| TomEnterprise AB |     | $              | 3,000,000 |     |                  | 1,200,000 |
| Trill AB         |     |                | 3,000,000 |     |                  | 1,200,000 |

In